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ABSTRACT 
Engineering Disease Resistance through Generation of an iPSC-derived P. Maniculatus Chimera 
Annie Nguyen 
Department of Biochemistry & Biophysics 
Texas A&M University 
Alison Zill 
Department of Biomedical Sciences 
Texas A&M University 
Research Advisor: Dr. David W Threadgill 
Department of Veterinary Pathobiology 
Texas A&M University 
 The goal of this project is to develop methods to manipulate the genome of Peromyscus 
maniculatus for the future eradication of diseases such as Hantavirus and Lyme disease that this 
species can transmit to humans. The initial thrust of this project is to generate induced 
pluripotent stem cells (iPSCs) from P. maniculatus mouse embryonic fibroblasts (MEFs) using 
an engineered Sendai Virus vector system. The Sendai Virus vector is a non-integrating viral 
vector that delivers four transcription factors necessary to reprogram normal somatic cells to a 
pluripotent, stem cell-like state. Subsequent, a plasmid will be used to insert DNA into the 
genome of the iPSC that codes for a fluorescent protein. In the future, the fluorescence will be 
used to confirm that Mus musculus cells are able to combine with the P. maniculatus cells in a 
chimeric blastocyst. Because many notable diseases are transmissible to humans from P. 
maniculatus, the genetic manipulation and creation of a disease resistant P. maniculatus using 
iPSCs could help to eradicate the spread of these diseases.  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NOMENCLATURE 
iPSCs  Induced Pluripotent Stem Cells  
MEFs  Mouse Embryonic Fibroblasts 
GFP  Green Fluorescent Protein 
RFP  Red Fluorescent Protein  
PBS  Phosphate-Buffered Saline 
LB  Luria Broth 
SeV  Sendai Virus  
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CHAPTER I 
INTRODUCTION 
Peromyscus maniculatus, a North American native mouse species, is known to be a 
reservoir for various diseases that are transmissible to humans, such as Lyme disease and 
Hantavirus (Richter, Spielman et al. 1998). Genetically engineering disease resistance in P. 
maniculatus could be a powerful approach to stop the spread of these diseases, but is currently 
not feasible since methods for assisted reproduction in Peromyscus have yet to be developed.  
With advances in induced pluripotent stem cell (iPSC) technology (Yamanaka 2008), 
there is an opportunity for creating disease resistant P. maniculatus. However, the generation of 
iPSCs from P. maniculatus was not previously possible due to this species being non-permissive 
to reprogramming to a pluripotent state under normal culture conditions. Therefore, more 
advanced conditions including signal pathway inhibitors must be used in order to allow the 
MEFs to be reprogrammed into the desired iPSCs. The iPSCs are generated from MEFs through 
usage of a Sendai Virus vector, which is ideal since the viral genes do not insert into the host cell 
genome and the transgenes coding for specific transcription factors stay in the cytoplasm 
(Nakanishi and Otsu 2012). The host cell eventually starts expressing endogenous versions of the 
transcription factors. 
The Sendai Virus vector is not the only way to generate iPSCs, however. Retroviral 
vectors have been used to introduce reprogramming factors, and the silencing of the transgenes 
displays successful reprogramming. Lentiviral vectors are more efficient at gene delivery, but the 
transgenes are more resistant to being silenced compared to retroviral vectors. Since transgenes 
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can interfere with functional genes, adenoviral vectors are used because the vectors integrate 
with the genome at low frequencies and the transgenes do not transfer into the host genome. The 
downside to this is that the cells are not reprogrammed as efficiently as they would be with a 
retroviral vector. A Cre-excisable lentivirus system can generate iPSCs, but there is a risk of gene 
breaks being inserted into the genome because of the LoxP sequence. To avoid introducing 
genetic material into the cell’s genome, synthetic mRNAs can also be used to reprogram cells to 
a pluripotent state. This method reprograms cells more efficiently than retroviral vectors (Seki 
and Fukuda 2015).  
The Sendai Virus vector is optimal for this experiment because it can be used in multiple 
cell types from different species. Genetic background can influence cells becoming iPSCs, and 
the variability of the Sendai Virus is the best option to use in this case (Schnabel, Abratte et al. 
2012). The virus will allow for cell differentiation since it is not retained in the host genome.  
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CHAPTER II 
METHODS 
Sendai Virus Transduction and Clearing 
In order for the Peromyscus maniculatus mouse embryonic fibroblasts (MEFs) to be 
reprogrammed into induced pluripotent stem cells (iPSCs), the Sendai Virus vector that contains 
genes coding for stem cell transcription factors will be used. This vector transmits the four 
Yamanaka factors, Oct4, Sox2, Klf4 and Myc to the MEFs. The Sendai Virus vector is ideally 
suited for the reprogramming of somatic cells because it does not integrate into the host genome, 
can infect a broad range of hosts, and replicates only in the cytoplasm of infected cells, among 
many other advantages. Most rodent species’ somatic cells are not permissive to reprogramming 
to a pluripotent state, so we use additional supplements to drive the P. maniculatus fibroblasts to 
iPSCs. These virus-transfected cells will then be passaged 10-15 times; during this time, iPSC 
colonies will be subcloned and separated based on gender, using sex-specific primers to detect X 
versus Y chromosomes present in each colony. Passaging the cells will slowly eliminate the virus 
and allow these fibroblasts to be transformed into the desired iPSCs. Clearing of the viral vectors 
and expression of the Yamanaka endogenous stem cell markers is verified by PCR with primers 
for each gene.  
Subcloning 
 To allow individual iPSC colonies to continue their growth, they are removed from the 
original 6-well plate and placed into a new 6-well plate in a process called subcloning. The 
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colonies can also be used to collect cDNA which is analyzed using PCR. To start the subcloning 
process, phosphate-buffered saline (PBS) and 2iS medium are warmed to 37°C. Next, 300µL of 
trypsin is added to a 12-well plate where the colonies will be broken up. A 0.1% gelatin-coated 
plate with 1mL of 2iS medium will be prepared for the newly subcloned cells. The media is 
aspirated out of the original 6-well plate, and then each well is rinsed with 1mL of PBS twice. 
The first individual colony is picked up with a wide-bore pipette tip at a setting of 50µL. The 
colony is released from the gelatin plate with a small twist, and is placed into the 300µL of 
trypsin. The plate is incubated for 4 minutes to allow the trypsin to start breaking up the colony, 
then 700µL of 2iS medium is added to the mixture and pipetted to break up the rest of the 
colony. This mixture is added to the new 6-well plate and the process is repeated for all of the 
colonies being subcloned. 
Reverse Transcription PCR 
 Reverse transcription PCR is used to obtain cDNA from iPSCs. The primers used include 
the Sendai Virus Transgene Primers, SEV, KOC, KLF4, and C-MYC, and the Murine 
Endogenous Stem Cell Markers, Oct 3/4, Klf4, c-Myc, and Sox-2. The PCR is used to check for 
the elimination of the Sendai Virus vectors with specific transgene primers, and to verify the 
pluripotency with murine-specific endogenous stem cell markers. 
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CHAPTER III 
RESULTS AND DISCUSSION 
Sendai Virus Vector 
Figure 1. Non-integration of Sendai Virus Vector into host genome 
 As shown in Figure 1, the Sendai Virus vector does not integrate into the host genome, 
unlike other vectors. The Sendai virus vector undergoes transcription and replication all within 
the cytoplasm of the infected cells, which allows the vector to deliver and express key genetic 
factors necessary for the reprogramming of the somatic cells.  Temperature-sensitive point 
mutations are introduced in viral polymerase genes P and L so that they could be easily removed 
at non-permissive temperatures (Yamanaka 2008). Therefore, the Sendai Virus is ideally suited 
for reprogramming a genetic reference population of MEFs that can accurately represent the 
diversity present in the human population.  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Reprogramming of MEFs into iPSCs 
Figure 2. Morphological change from MEFs to iPSCs 
Figure 3a. iPSC reprogramming post SeV transduction. Left, Day 7; Right, Day 18. 
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Figure 3b. iPSC reprogramming post SeV transduction. Left, Day 24; Right, Week 8.  
 The Sendai Virus vector is able to successfully reprogram MEFs into iPSCs. Figure 2 
shows the morphological distinction between the MEFs and the reprogrammed iPSCs. Fibroblast 
cells are elongated and attach to the bottom of the plate, while iPSCs are rounder and aggregate 
into colonies. This is one way to confirm the successful generation of iPSCs. Figures 3a and 3b 
indicate the change post Sendai Virus transduction up to 8 weeks. Seven days after transduction, 
the fibroblasts are still present, but more rounded cells are seen on the plate. This indicates that 
the cells are in the process of becoming iPSCs. Eighteen days post transduction shows the 
aggregation of cells and the formation of what will become a colony. As more time goes by, there 
is a decrease of MEFs and an increase of iPSCs, which indicates successful reprogramming. By 
week 8, there seems to be no sign of MEFs.  
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Passaging Cells 
 Throughout the life cycle of the cells, they need to be passaged on a regular basis to 
ensure proper growth and colony formation. The first type of passaging used is bulk passaging. 
This method is used before and after the cells are transfected with the Sendai Virus Vector to 
allow for continued growth. Once the cells are about 70% confluent, they are passaged to various 
dilutions depending on the cell density. Passage dilutions vary from 1:2 for plates with fewer 
cells to 1:50 for plates that are completely confluent. The passaging allows for the cells to have 
room to divide, and to eliminate the Sendai Virus Vector. 
 Once colonies form, the cells are passaged through subcloning. Using a wide-bore pipet, 
individual colonies are picked up from the plate and broken up in trypsin. Once the cells are 
added to a new plate, they are able to form new colonies. This method is used to eliminate the 
MEFs that failed to be transduced with the Sendai Virus Vector. After multiple rounds of 
subcloning, no MEFs remain and the stem cells can continue to grow. The problem with 
excessive MEFs is that they grow rapidly and take up space that stem cells could be growing and 
forming colonies in, and subcloning eliminates this problem. Subcloning is also used to eliminate 
the Sendai Virus Vector. 
 MEF depletion is used when subcloning fails to eliminate most, if not all, of the MEFs. 
When colonies are subcloned at a small size, MEFs can be subcloned along with the stem cells. 
This allows for the continued growth of both MEFs and stem cells, when only stem cell growth 
is desired. To overcome the excessive population of MEFs, a process called MEF depletion is 
used to isolate the stem cells. Trypsin is added to the cells to release them from the plate, then 
media is added to deactivate the trypsin. The media-cell mixture is added to a new gelatin-coated 
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plate and allowed to incubate anywhere from 30 minutes to 2 hours, depending on how long it 
takes the MEFs to attach to the plate. Since MEFs attach more quickly than stem cells, the media 
only contains stem cells. This media is placed onto a new plate and the stem cells are allowed to 
grow without influence from MEFs. 
 After multiple passaging of the cells, it was discovered that there weren’t many iPSC 
colonies growing in the plates. This could be due to the fact that the MEFs that are still present 
are overcrowding the plate and won’t allow the iPSCs room to attach. In order to get rid of 
excess MEFs found in the plates, MEF depletion was performed. 
Elimination of SeV and Verification of Pluripotency  
Figure 4a. Sendai Virus Transgene Primers 
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Figure 4b. Endogenous Murine Stem Cell Markers 
  
 In the gel images, the MEFs serve as the negative control and should not be expressing 
Sendai primers. This is because they have never been transduced. The SeV transgenes are human 
genes so they definitely should not be expressing SeV transgenes. The p15 lane in figure 4a 
indicates that a parallel cell line at passage 15 has been cleared of the Sendai Virus transgenes 
that were introduced to the cells during transduction. Expression of murine endogenous stem cell 
markers is verified in Figure 4b. Although there are bands in the MEF lanes, they key point to 
note is that there are not bands present in all of them. The MEFs are expressing two out of the 
four genes because not all genes are specific for one type of cell. The Klf4 and c-Myc markers 
that the MEFs are expressing are good indicator of stem cells, but they are also involved in 
proliferation of other cells. The fact that the iPSCs (p15) are expressing all four markers verifies 
that they are stem cells.  
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CHAPTER IV 
FUTURE PLANS  
Bacterial Transformation 
  It is important to streak the bacteria on a Luria Broth (LB) agar plate in order to isolate 
single colonies of bacteria. To begin, an LB agar plate was obtained with the antibiotic ampicillin 
(100 ug/mL). Using a sterile loop, the bacteria from the punctured stab culture was inoculated 
onto the agar plate using the streak technique. The plate was then incubated overnight for 12-18 
hours at 37°C. In order to obtain a large amount of bacteria containing the plasmid, an overnight 
liquid culture of the plasmid must be inoculated. First, the liquid LB is prepared using NaCl, 
tryptone, yeast extract, and dH2O. It is then autoclaved and stored at room temperature. When 
ready, the broth is added to a tube with the appropriate antibiotic at the desired concentration. A 
single colony from the streaked LB agar plate is selected and inoculated into the tube of LB and 
antibiotic. The culture is then swirled, covered loosely with aluminum foil, and incubated at 
37°C for 12-18 hours in a shaking incubator. The plasmid DNA can then be stored for a long 
period of time using a glycerol stock. Once ready, the plasmid DNA is isolated from the bacterial 
cells through lysis and separation of the proteins, RNA, and chromosomal SNA from the plasmid 
DNA. 
Purification of Plasmid 
 To purify the plasmid that will be introduced into the P. maniculatus iPSCs, a colony of 
bacteria is streaked from a plate and added to the LB medium. The tube is then incubated at 37°C 
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and vigorously shaken for 12-16 hours. The bacterial cells are harvested by centrifugation at 
>8,000 RPM for 3 minutes, then the supernatant is discarded. The pellet of bacterial cells is 
resuspended in 250µL of Buffer P1 and then transferred to a microcentrifuge tube. Next, 250µL 
of Buffer P2 are added and the tube is gently inverted 4-6 times. The solution should look 
viscous and slightly clear. Then, 350µL of Buffer N3 is added and the use is immediately 
inverted 4-6 times. The solution should look cloudy. The tube is then centrifuged for 10 minutes 
at 13,000 RPM, and a white pellet should form. A QIAprep spin column is added to a 2mL 
collection tube, and the supernate from the centrifugation is added to the column. This is 
centrifuged for 30-60 seconds and the flow-through is discarded. Following centrifugation, 
0.75mL of Buffer PE is added to the column and centrifuged again for 30-60 seconds. The flow-
through is again discarded and the column is centrifuged for one more minute to remove residual 
wash buffer. Then the column is placed in a clean microcentrifuge tube and can then be used to 
elute DNA. 
Restriction Digests  
 Restriction analysis is used to verify that the correct plasmid is present. To start, the 
restriction digests were prepared, each containing: 7uL sterile water, 2uL 10X FastDigest buffer, 
10uL of plasmid DNA, and 1uL of the appropriate Fast Digest enzyme. These came to a total 
volume of 20uL. For double digests, 6uL of sterile water was used with 1uL of each of the two 
enzymes. The digests were mixed gently, centrifuged, and placed on a 37°C heat block for 10 
minutes to incubate. Next, 4uL of 6X loading dye was added to each of the samples. The samples 
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were loaded onto a 2% agarose gel and run at 120 V. Once the correct plasmid is confirmed, the 
appropriate restriction enzyme is used to linearize the plasmid for use in transfection.  
Antibiotic Sensitivity 
 Before the plasmid is added to the cells, gentamicin is added to a subset of stem cells to 
verify their sensitivity to the antibiotic. Once the cells are transfected with the plasmid, they are 
exposed to the antibiotic once again. The cells that survive the antibiotic exposure have 
successfully taken up the plasmid and are therefore antibiotic resistant. 
Transfection of Fluorescent Plasmid 
 Future experiments will include injection of P. maniculatus iPSCs into a Mus musculus 
blastocyst to form a chimera that can later breed with normal P. maniculatus. In order to verify 
that, in the future, P. maniculatus iPSCs injected into a Mus musculus blastocyst are indeed 
integrated into the blastocyst, green fluorescent protein (GFP) and red fluorescent protein (RFP) 
will be used to distinguish the two individuals’ cells. A plasmid that expresses RFP will be used 
to insert the DNA into the cell, which then will insert itself into the cell’s genome. A non-cytoxic 
chemical will be used to permeabilize the membrane for the DNA to enter the cell. 
Creating a Chimera 
Fluorescence will be used to ensure that the blastocyst will integrate with the P. 
maniculatus iPSCs. Once the iPSCs are fully reprogrammed and cleared of the viral vectors, 
future plans are transfection of the fluorescence-expressing iPSCs into a Mus musculus 
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blastocyst. Because of the considerable genetic resources available for this common lab mouse, it 
is likely that using a M. musculus female for implantation of a P. maniculatus iPSC-injected 
blastocyst will aid in the successful generation of a chimera (Guo, Wu et al. 2014). Disease 
resistant genes will eventually be introduced into the iPSCs to be expressed in the chimera, 
which should then be able to successfully reproduce with wild P.  maniculatus and transmit 
disease resistance in the future. 
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